A pharmaceutical company can apply for preapproved reimbursement for a drug that has received marketing authorization
This information may be inaccurate due to changes in regulations from January 1 2018. Updated information will be published in English shortly. Please send an email to email@example.com if you have any questions.
Applicants must pay a reimbursement fee for processing the application. The Norwegian Medicines Agency will approve or reject the application within 180 days. If the Norwegian Medicines Agency requests for supplementary information, the time limit is increased beyond the 180 days.The application must be designed in accordance to the
template for reimbursement applications. An important part in the template is pharmaco-economic analyzes - these must be based on the
guidelines for pharmaco-economic analyzes as well as the
requirements regarding use of time-to-event data when applicable. Applications should be sent either to firstname.lastname@example.org or by mail.
guidance to identify and discuss any uncertainties relating to the reimbursement process and the preparation of the reimbursement application.
Price and reimbursement list updated 2016-09-01 (Excel)
The list contains price and reimbursement information on all prescription-only medicines for humans with a maximum price in Norway. The maximum PPP (exclusive VAT) and the maximum PRP (inclusive VAT) are given. Please note that these are maximum prices and the actual prices may therefore be lower than stated.
More information on maxium price.